These findings are consistent with many previous findings that astaxanthin can inhibit the development of precancerous lesions in colon cancer by reducing oxidative stress, alleviating chronic inflammation, and inhibiting NF-κB activation and colon mucosal cell proliferation [47]. Here, NFKB1 is linked to colonic neoplasm.